The Melanocortin Receptor Family Explained (2026): MC1R Through MC5R

Most readers meet the melanocortin system through a single compound and never see the larger map. But melanocortin pharmacology only makes sense at the level of the receptor family — five related receptors, one shared ligand system, and a selectivity problem that defines the entire field. This guide walks through MC1R to MC5R systematically: what each does, where the ligands come from, and why "which receptors does this compound hit, and how selectively" is the question every melanocortin peptide ultimately answers. It is established receptor biology, framed for research use only — no cosmetic, tanning, or human-outcome claims.

One ligand system, five receptors

The melanocortin receptors are a family of five class A G-protein-coupled receptors — MC1R, MC2R, MC3R, MC4R, and MC5R. They share two defining traits: all five couple to the Gs protein and raise intracellular cyclic AMP (cAMP), and all respond to peptides cleaved from a single precursor protein, proopiomelanocortin (POMC).

POMC is processed into the melanocyte-stimulating hormones (α-, β-, and γ-MSH) and adrenocorticotropic hormone (ACTH). These are the native melanocortin agonists. The system also has endogenous antagonists — agouti and agouti-related peptide (AgRP) — which is unusual: most GPCR families do not have natural blocking ligands. That agonist/antagonist tension is part of what makes melanocortin signaling a rich research subject.

The five receptors at a glance

A few features stand out. MC2R is the odd one out — it responds essentially only to ACTH, not to the MSH peptides, and is tied to the adrenal steroidogenesis pathway rather than to the pigmentation or central effects the other subtypes are known for. MC1R and MC4R are the two most relevant to the research-peptide conversation, because they are the receptors engaged by the melanocortin analogs that circulate in the research market.

MC1R: the pigmentation receptor

MC1R sits on melanocytes, the pigment-producing cells of skin and hair. Agonism here is associated with melanogenesis — the synthesis of melanin. This is the receptor that the original melanocortin research program set out to study, on the logic that melanin is the body's own UV defense and a stable α-MSH analog would be a useful photoprotection-research tool. MC1R agonism is, in short, the "tanning" arm of the family in mechanistic terms — though we make no cosmetic claim and frame it only as pigmentation biology.

MC4R: the central receptor

MC4R is expressed largely in the central nervous system and is one of the most-studied GPCRs in energy-balance research. It is associated with appetite regulation and energy homeostasis, and — the observation that launched a whole research line — with central arousal pathways. It was the discovery that a melanocortin metabolite produced MC4R-mediated central effects that spun off the PT-141 research program from the broader melanocortin work.

The MC1R-versus-MC4R contrast is the cleanest illustration of why the family must be understood as a set. The same class of peptide ligand can drive pigmentation through one receptor and central signaling through another, depending entirely on which subtype it engages and how strongly.

Selectivity: the central design problem

Here is the through-line of melanocortin pharmacology. Because the five receptors govern different physiology in different tissues, the key property of any melanocortin compound is its selectivity profile across the family.

• A non-selective agonist activates broadly across MC1R, MC3R, MC4R, and MC5R at once. That breadth makes it a powerful but blunt research tool — it pulls several pathways simultaneously, which complicates isolating any single effect. Melanotan II is the textbook example of a non-selective melanocortin agonist; see the melanotan II research profile.
• A more selective compound narrows its activity toward fewer subtypes, producing a cleaner experimental signal. PT-141, melanotan II's metabolite, shifted toward central MC4R-relevant signaling — a more focused profile carved out of a non-selective parent.

You can review the two best-known melanocortin research compounds — melanotan-2 and pt-141 — in our catalog, and browse the full reference library at /peptides.

What is settled and what isn't

The family structure — five receptors, POMC-derived ligands, Gs/cAMP coupling, the broad tissue assignments — is established molecular biology. What remains an active research frontier is the finer pharmacology: subtype-specific biased signaling, the exact selectivity profiles of individual analogs, and receptor desensitization kinetics. So the map of the family is settled; some of the fine detail per receptor is still being characterized. And the regulatory status of melanocortin research compounds is separate from any of this biology — several are unapproved for human use and are framed here for research only.

Why receptor knowledge still demands material rigor

Knowing the family cold does not validate the vial. Melanocortin peptides like melanotan II and PT-141 are cyclic, structurally close cousins, and easy to mislabel or substitute — which makes mass-spec identity confirmation more than a formality. Insist on a batch-specific Certificate of Analysis with third-party HPLC purity and a correct observed mass. Start with our compound buying guides and the 2026 research methodology.

Bottom line

The melanocortin system is a five-receptor family sharing one POMC-derived ligand system and a common Gs/cAMP cascade, with each subtype — MC1R pigmentation, MC2R adrenal, MC3R/MC4R metabolic and central, MC5R glandular — governing different physiology. Because the receptors diverge by tissue, selectivity is the defining pharmacological property, and the real biological difference between related compounds rather than raw potency. Map the family first, then ask which subtypes any given peptide engages. For verification once the biology is clear, see our compound buying guides.

For research use only. This content is informational and does not constitute medical or dosing advice. All compounds referenced are for laboratory research use only — not for human consumption.

Disclosure: Peptide Research Review maintains affiliate relationships with some of the suppliers we reference. Affiliate status has no influence on our research framing or our blinded, third-party lab evaluations. Read our editorial policy and methodology.